Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
seletracetam
- Development stage
- Phase 3
- Lead developer
- Prevep
- Modality
- Small Molecules
- Administration
- Oral, Intravenous
01
Overview
Seletracetam is a pyrrolidone-derived antiepileptic drug candidate structurally related to levetiracetam. It was developed as a next-generation analog of levetiracetam with the aim of providing improved efficacy and tolerability for the treatment of epilepsy. Like levetiracetam, seletracetam acts primarily by binding to synaptic vesicle glycoprotein 2A (SV2A), modulating neurotransmitter release and reducing neuronal hyperexcitability associated with seizures. Seletracetam also exhibits inhibitory effects on voltage-gated calcium channels, which may contribute to its anticonvulsant properties. The drug was developed by UCB but its clinical development has been discontinued.
- Other names
- seletracetam intranasalseletracetam
02
Targets
CACNA1B (Voltage-dependent N-type calcium channel subunit alpha-1B)SV2A (Synaptic vesicle glycoprotein 2A)
Beyond the preview
Go deeper on seletracetam.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on seletracetam.